News

Filter

Current filters:

Servier

1 to 9 of 289 results

Hybrigenics extends its partnership with Servier

27-01-2015

French biopharma company Hybrigenics says it has extended its partnership with France’s leading independent…

HybrigenicsOncologyPharmaceuticalResearchServier

GeNeuro and Servier partner on multiple sclerosis drug candidate GNbAC1

03-12-2014

Switzerland-based drug developer GeNeuro has entered into a strategic partnership with French independent…

GeNeuroLicensingNeurologicalPharmaceuticalResearchServier

EMA makes recommendation for reducing heart attack risk of Servier's Corlentor/Procoralan

EMA makes recommendation for reducing heart attack risk of Servier's Corlentor/Procoralan

21-11-2014

The European Medicines Agency has reviewed angina medication Corlentor/Procoralan (ivibradine), manufactured…

Cardio-vascularEuropePharmaceuticalProcoralanRegulationServier

Servier gains ex-US/Japan rights to Intarcia diabetes product ITCA 650

Servier gains ex-US/Japan rights to Intarcia diabetes product ITCA 650

12-11-2014

USA-based biotech firm Intarcia Therapeutics has started a strategic partnership with French independent…

BiotechnologyDiabetesexenatide pumpFranceIntarcia TherapeuticsITCA 650LicensingServier

EMA PRAC’s recommendations to reduce risk of heart problems with ivabradine

09-11-2014

The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) has completed a…

AmgenCardio-vascularEuropeivabradinePharmaceuticalProcoralanRegulationServier

Servier’s new research partnership with Walter and Eliza Hall Institute

Servier’s new research partnership with Walter and Eliza Hall Institute

04-10-2014

French independent pharma company Servier has established a collaborative partnership with Australia’s…

AustraliaFranceOncologyPharmaceuticalResearchServier

Servier and Pharmacyclics end collaboration on abexinostat pan-HDAC inhibitor compounds

Servier and Pharmacyclics end collaboration on abexinostat pan-HDAC inhibitor compounds

26-09-2014

French privately-held drugmaker Servier is to end its collaboration with Pharmacyclics in the development…

abexinostatBiotechnologyFranceOncologyPharmacyclicsResearchServier

Servier and CTI Biopharma collaborate on Pixuvri

23-09-2014

Leading French independent drugmaker Servier and US biotech firm CTI BioPharma have entered into an exclusive…

BiotechnologyCTI BioPharmaLicensingOncologyPixuvriServier

1 to 9 of 289 results

COMPANY SPOTLIGHT

Menarini

Back to top